Your Location:
Home >
Browse articles >
Gandouling Regulates PI3K/Akt/mTOR Autophagy Signaling Pathway via LncRNA H19 for Treatment of Wilson Disease Liver Fibrosis
Gandouling Regulates PI3K/Akt/mTOR Autophagy Signaling Pathway via LncRNA H19 for Treatment of Wilson Disease Liver Fibrosis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 1, Pages: 131-138(2025)
DOI: 10.13422/j.cnki.syfjx.20241503
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 5 ) Tabs( 5 )
References
Publication Info
Metrics
341
Views
441
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Clinical Efficacy of Gandou Fumu Granules in Intervention of Liver Fibrosis in WD Patients with Phlegm and Blood Stasis Syndrome and Effect on Cuproptosis-related Indicators
Modified Taohe Chengqitang Regulates Notch/eNOS Signaling Pathway to Inhibit Hepatic Sinusoidal Capillarization
Danshen Zexie Decoction Ameliorates Metabolic-associated Fatty Liver Disease with Liver Fibrosis by Regulating Glycolysis and Inhibiting NETs
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis: A Review
Related Author
HUA Daiping
SUN Lanting
XU Yunyun
YANG Wenming
WANG Fei
JIANG Zhenzhen
CHEN Yimin
TAO Zhuang
Related Institution
Graduate School of Anhui University of Chinese Medicine
The Healthcare Center for Shishan Street of Suzhou New District
Graduate School of Anhui University of Traditional Chinese Medicine
School of Basic Medical Sciences,Zhejiang Chinese Medical University
The First Affiliated Hospital of Hebei University of Chinese Medicine


